GGrantIndex
Sort

40,608 grants matching prostate cancer

Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females

$692,527
Tony Yuen · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AG

Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ

$692,491
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

A non-invasive blood test for multi-cancer detection and determination of tissue of origin preceding overt cancer diagnosis

$692,491
Marc Bissonnette · University Of Chicago · U01 · FY2025 · CA

Molecular Phenotypes for Lung Diseases

$692,485
David Brian Corry · Baylor College Of Medicine · R01 · FY2009 · HL

Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study

$692,378
James Graham Wilson · University Of Mississippi Med Ctr · R01 · FY2008 · HL

3D Prostate Cancer Imaging Based on "Crawling Wave" Excitation

$692,353
Deborah J. Rubens · University Of Rochester · R01 · FY2009 · AG

Leadership, Planning, and Evaluation

$692,337
Stanton L Gerson · Case Western Reserve University · P30 · FY2021 · CA

Incorporating Biomarkers to Improve Lung Cancer Risk Prediction

$692,318
Ziding Feng · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · CA

Early Diagnosis of Pancreatic Cancer

$692,241
Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2008 · CA

Molecular Phenotypes for Lung Diseases

$692,215
David Brian Corry · Baylor College Of Medicine · R01 · FY2010 · HL

Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer

$692,072
Martin G Pomper · Ut Southwestern Medical Center · R01 · FY2024 · CA

Dual-Tracer PET Tumor Imaging

$692,035
Dan J Kadrmas · Multifunctional Imaging, Inc. · R44 · FY2023 · CA

Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer

$692,001
Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2025 · CA

Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer

$692,001
Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2023 · CA

(PQC4) Habitats in Prostate Cancer

$692,000
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA

Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)

$691,805
Debra L Friedman · Vanderbilt University Medical Center · R01 · FY2019 · CA

Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial

$691,713
Douglas Reding · Marshfield Clinic Research Foundation · N01 · FY2010 · CA

Northwest Community Clinical Oncology Program

$691,655
Lauren Colman · Tacoma General Hospital · U10 · FY2008 · CA

An integrative multi-omics approach to characterize prostate cancer risk in diverse populations

$691,648
Nicholas Mancuso · University Of Southern California · R01 · FY2021 · CA

Creation of in vivo active chemical probes for CAMKK2 to treat cancer

$691,617
David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA

H. LEE MOFFITT CANCER CENTER CCOP RESEARCH BASE

$691,431
University Of South Florida · U10 · FY2002 · CA

PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization

$691,313
James Peter Basilion · Case Western Reserve University · R01 · FY2021 · CA

Prostate Cancer Immunotherapy

$691,169
Robert B Darnell · Rockefeller University · R01 · FY2007 · CA

Mouse Cancer Models for Integrated Tissue/Serum Proteomics and Molecular Imaging

$690,973
Sanjiv S Gambhir · Stanford University · U54 · FY2010 · CA

DATA SCIENCE TO IMPROVE TREATMENT PLANNING FOR ADVANCED PROSTATE CANCER PATIENTS TREATED WITH RADIOTHERAPY

$690,912
H. Lee Moffitt Cancer Center And Research Institute Lifetime Cancer Screening Center, Inc. · · FY2022 · Defense Health Agency